GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 2 filers reported holding GW PHARMACEUTICALS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $98,209,000 | +90.0% | 452,783 | +1.1% | 0.73% | +104.8% |
Q4 2020 | $51,684,000 | +39.6% | 447,828 | +17.8% | 0.36% | +16.3% |
Q3 2020 | $37,014,000 | -8.3% | 380,217 | +15.7% | 0.31% | -11.5% |
Q2 2020 | $40,343,000 | +58.4% | 328,739 | +13.0% | 0.35% | +17.6% |
Q1 2020 | $25,468,000 | -3.2% | 290,830 | +15.6% | 0.30% | +17.1% |
Q4 2019 | $26,314,000 | +0.6% | 251,664 | +10.7% | 0.25% | -0.8% |
Q3 2019 | $26,151,000 | -6.9% | 227,338 | +39.5% | 0.25% | -4.5% |
Q2 2019 | $28,088,000 | +48.6% | 162,934 | +45.3% | 0.27% | +39.3% |
Q1 2019 | $18,898,000 | +129.8% | 112,107 | +32.7% | 0.19% | +92.9% |
Q4 2018 | $8,225,000 | -5.2% | 84,453 | +68.2% | 0.10% | +25.3% |
Q3 2018 | $8,672,000 | +33.3% | 50,203 | +7.6% | 0.08% | +17.9% |
Q2 2018 | $6,508,000 | +52.3% | 46,642 | +23.0% | 0.07% | +36.7% |
Q1 2018 | $4,274,000 | -13.1% | 37,930 | +1.7% | 0.05% | -18.3% |
Q4 2017 | $4,921,000 | +43.6% | 37,280 | +10.4% | 0.06% | +42.9% |
Q3 2017 | $3,427,000 | +6.7% | 33,769 | +5.4% | 0.04% | +7.7% |
Q2 2017 | $3,213,000 | -14.1% | 32,049 | +3.6% | 0.04% | -22.0% |
Q1 2017 | $3,741,000 | +16.1% | 30,936 | +7.3% | 0.05% | +6.4% |
Q4 2016 | $3,223,000 | – | 28,844 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|